This issue of the *Kidney International Supplements* contains the proceedings of the Fifteenth National Congress on Hypertension and Renal Diseases that took place in Antalya, Turkey on 24--28 April 2013. The Turkish Society of Hypertension and Renal Diseases has organized scientific meetings annually since 1999, with participation from medical schools and other health-care institutions across Turkey. The 15th annual national congress is an academic landmark for the society, and it provided an opportunity to evaluate established paradigms and review new data on hypertension and kidney diseases in general and as they relate to affected populations in Turkey.

This year\'s congress was dedicated to examining the extent of hypertension and its cardiovascular complications in Turkey along with evaluation of the lessons learned from high-quality landmark trials in the United States and Europe. Invited guests and participants from Turkey, Europe, and the United States discussed the recent insight into the pathophysiology of hypertension and the multifaceted approach to treatment of hypertension in vulnerable populations including women.

The proceedings of this congress also included sessions to assess the burden of chronic kidney disease in Turkey, and reviewed recent progress on the treatment of anemia, dyslipidemia, calcium, and phosphate disturbances and management of patients on dialysis. Other relevant themes of particular interest for discussion were the new biomarkers in kidney injury, the therapeutic approaches to resistant and severe hypertension, and management of hypertension in dialysis patients.

Selected materials presented in this congress merit publication in a leading nephrology journal such as the *Kidney International*. We are grateful to all distinguished contributors to the congress for both their presentations and their published papers. We wish to express our gratitude to the editorial staff in helping us to make this supplement possible.

It has been our privilege and honor to serve as Guest Editors of this special issue, and we hope that it will prove useful to clinicians, and help further stimulate continued research and public health efforts aimed at reducing the burden of hypertension and kidney diseases in Turkey and elsewhere.
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